DSP Merrill Lynch, manager to the Delisting Offer, on behalf of Fresenius Kabi (Singapore) Pte Ltd has informed this exit offer Public Announcement to the Equity Shareholders of the Fresenius Kabi Oncology. Money Control, 2 months ago
1 images for "fresenius kabi of singapore"
Pfizer's $3.5m expansion of an Indonesian solid oral dose plant will increase capacity by 76%, the company says. The Pfizer Global Supply (PGS) facility in East Jakarta manufactures formulated drugs for the treatment of cardiovascular diseases, ...In-Pharmatechnologist, 6 days ago
DUBLIN, Mar. 07, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/m57wxd/enteral_feeding ) has announced the addition of the " " report to their offering. (Logo: ...Yahoo! Finance, 1 week ago
Mumbai, March 3: Sweden's AstraZeneca Pharmaceuticals AB has made a delisting offer to shareholders of its Indian subsidiary AstraZeneca Pharma India Ltd. AstraZeneca Pharma India today announced that its board of directors would meet on March 5 to ...Calcutta Telegraph, 1 week ago
on your WebpageAdd Widget >Get your members hooked!